Saiki Y, Ohtani H, Naito Y, Miyazawa M, Nagura H
Department of Pathology, Tohoku University School of Medicine, Aoba-ku, Sendai, Japan.
Lab Invest. 1996 Jul;75(1):67-76.
A subset of gastric carcinoma carries Epstein-Barr virus (EBV). The immunophenotypic features of EBV-associated (EBV+) gastric carcinoma, which we have analyzed using 25 EBV+ cases, remain unclear. Frozen tissue samples were stained with antibodies to various immune cell markers. To evaluate the proliferative activity of CD8+ cells, we performed CD8/Ki-67 double staining on paraffin-embedded sections. The results were compared with those in EBV-negative (EBV-) gastric carcinomas. All EBV+ and EBV- gastric carcinoma cells expressed major histocompatibility complex class I, whereas major histocompatibility complex class II expression in tumor cells was more prominent in EBV+ cases. Intercellular adhesion molecule-1 and Fas/APO-1 expression was largely restricted to EBV+ cases. The lymphocytes that infiltrated EBV+ tumor nests were predominantly CD8+ T cells, many of which expressed perforin. Immunoelectron microscopy confirmed a close cell to cell contact between these CD8+ cells and carcinoma cells. CD8+ cells were CD11a+ and CD11b- by flow cytometry performed in one case. The labeling index of Ki-67, the proliferation-associated antigen, in CD8+ cells was 4 times higher in EBV+ cases than in EBV- cases. Our data suggest that these CD8+ cells, which bear a cytotoxic phenotype, are actively proliferating in close contact with EBV+ tumor cells and that the specificity of the CD8+ cells may be directed to EBV and/or cellular antigens expressed by the tumor. This is consistent with a generally favorable prognosis of EBV+ gastric carcinoma. Because the observed T-cell infiltration is insufficient to eradicate the tumor cells, certain immunosuppressive factors were speculated to allow the essentially immunogenic carcinoma cells to establish a macroscopic lesion.
一部分胃癌携带爱泼斯坦-巴尔病毒(EBV)。我们对25例EBV相关(EBV+)胃癌的免疫表型特征进行了分析,但其特征仍不明确。冷冻组织样本用针对各种免疫细胞标志物的抗体进行染色。为了评估CD8+细胞的增殖活性,我们在石蜡包埋切片上进行了CD8/Ki-67双重染色。将结果与EBV阴性(EBV-)胃癌的结果进行比较。所有EBV+和EBV-胃癌细胞均表达主要组织相容性复合体I类,而肿瘤细胞中主要组织相容性复合体II类的表达在EBV+病例中更为突出。细胞间黏附分子-1和Fas/APO-1的表达主要局限于EBV+病例。浸润EBV+肿瘤巢的淋巴细胞主要是CD8+ T细胞,其中许多表达穿孔素。免疫电子显微镜证实这些CD8+细胞与癌细胞之间存在紧密的细胞间接触。在一个病例中通过流式细胞术检测发现CD8+细胞为CD11a+和CD11b-。EBV+病例中CD8+细胞中增殖相关抗原Ki-67的标记指数比EBV-病例高4倍。我们的数据表明,这些具有细胞毒性表型的CD8+细胞与EBV+肿瘤细胞紧密接触并活跃增殖,并且CD8+细胞的特异性可能针对EBV和/或肿瘤表达的细胞抗原。这与EBV+胃癌总体预后较好是一致的。由于观察到的T细胞浸润不足以根除肿瘤细胞,推测某些免疫抑制因子使本质上具有免疫原性的癌细胞形成肉眼可见的病变。